Annovis Bio Inc (NYSEAMERICAN:ANVS) was the biggest percentage gainer on Friday and made an all-time high.
ANVS stock was volatile and soared 127.27% to close at $60.00 on Friday. The stock made a high and low of $97.97 and $34.75 respectively for the session after opening at $36.91. The total volume for the day was 38.39 million shares – 48X is average volume of 801K shares.
ANVS Released News This Week
Annovis Bio Announces Positive Phase 2 Data – ANVS401 Improves Cognition in Alzheimer’s Disease – Patients’ Cognition Improved 3.3 Points on ADAS-Cog11
- announced new results from a double-blind, placebo-controlled study of ANVS401, its lead drug candidate for the treatment of AD and PD. Patients treated with ANVS401 for 25 days showed statistically significant cognitive improvement as measured by the Alzheimer’s Disease Assessment Scale-Cognitive Subscale 11 (ADAS-Cog11).
- The 11-part test is one of the most frequently used tests to measure impaired cognition in clinical trials for AD.
Dr. Maria L. Maccecchini, CEO of Annovis Bio, explained: “We previously reported that ANVS401 significantly increased speed, coordination and motor function in PD patients in this trial.
|SHARES OUTSTANDING||6.95 M|
|SHARE FLOAT (%)||4.14 M (59.59%)|
|% HELD BY INSTITUTIONS||11.94|
Recent Stock Performance
|+/- EMA(20)||28.47 (+110.75%)|
|+/- SMA(50)||27.42 (+118.82%)|
|+/- SMA(200)||13.83 (+333.84%)|
|CCI20||613.1727||OverBought||Chaikin Money Flow||-0.1920||Sell|
|MACD||3.6563||Buy||Money Flow Index||99.0272||OverBought|
|STOCH (14,3)||50.8224||Buy||STOCH RSI||1.0000||OverBought|